-
1
-
-
0345549608
-
Determining a maximum cumulative dose: Dose reassignment within the tite-crm
-
Braun, T. M., Levine, J. E. Ferrara, J. (2003) Determining a maximum cumulative dose: dose reassignment within the tite-crm. Contr. Clin. Trials, 24, 669 681.
-
(2003)
Contr. Clin. Trials
, vol.24
, pp. 669-681
-
-
Braun, T.M.1
Levine, J.E.2
Ferrara, J.3
-
2
-
-
20744450408
-
Determining a maximum tolerated schedule of a cytotoxic agent
-
Braun, T. M., Yuan, Z. Thall, P. F. (2005) Determining a maximum tolerated schedule of a cytotoxic agent. Biometrics, 61, 335 343.
-
(2005)
Biometrics
, vol.61
, pp. 335-343
-
-
Braun, T.M.1
Yuan, Z.2
Thall, P.F.3
-
3
-
-
1542427732
-
A new bayesian model for survival data with a surviving fraction
-
Chen, M. H., Ibrahim, J. G. Sinha, D. (1999) A new bayesian model for survival data with a surviving fraction. J. Am. Statist. Ass., 94, 909 919.
-
(1999)
J. Am. Statist. Ass.
, vol.94
, pp. 909-919
-
-
Chen, M.H.1
Ibrahim, J.G.2
Sinha, D.3
-
4
-
-
0033637096
-
Sequential designs for Phase i clinical trials with late-onset toxicities
-
Cheung, Y. Chappell, R. (2000) Sequential designs for Phase I clinical trials with late-onset toxicities. Biometrics, 56, 1177 1182.
-
(2000)
Biometrics
, vol.56
, pp. 1177-1182
-
-
Cheung, Y.1
Chappell, R.2
-
5
-
-
0029027770
-
Some pratical improvements in the continual reassessment method for Phase i studies
-
Goodman, S., Zahurak, M. Piantadosi, S. (1995) Some pratical improvements in the continual reassessment method for Phase I studies. Statist. Med., 14, 1149 1161.
-
(1995)
Statist. Med.
, vol.14
, pp. 1149-1161
-
-
Goodman, S.1
Zahurak, M.2
Piantadosi, S.3
-
6
-
-
63849152456
-
Parametric likelihood approaches to determine a maximum tolerated schedule in phase i trials
-
University of Michigan. Ann Arbor.
-
Liu, C. A. (2007) Parametric likelihood approaches to determine a maximum tolerated schedule in phase I trials. PhD Thesis. University of Michigan, Ann Arbor.
-
(2007)
PhD Thesis.
-
-
Liu, C.A.1
-
7
-
-
0025148278
-
Continual reassessment method: A practical design for Phase i clinical trials in cancer
-
O'Quigley, J., Pepe, M. Fisher, L. (1990) Continual reassessment method: a practical design for Phase I clinical trials in cancer. Biometrics, 46, 33 48.
-
(1990)
Biometrics
, vol.46
, pp. 33-48
-
-
O'Quigley, J.1
Pepe, M.2
Fisher, L.3
-
8
-
-
0029938415
-
Continual reassessment method: A likelihood approach
-
O'Quigley, J. Shen, L. (1996) Continual reassessment method: a likelihood approach. Biometrics, 52, 673 684.
-
(1996)
Biometrics
, vol.52
, pp. 673-684
-
-
O'Quigley, J.1
Shen, L.2
-
10
-
-
0037201011
-
Competing designs for phase i clinical trials: A review
-
Rosenberger, W. Haines, L. (2002) Competing designs for phase I clinical trials: a review. Statist. Med., 21, 2757 2770.
-
(2002)
Statist. Med.
, vol.21
, pp. 2757-2770
-
-
Rosenberger, W.1
Haines, L.2
-
11
-
-
0038214425
-
-
SAS Institute. Cary. SAS Institute.
-
SAS Institute (1999) SAS Version 8 for Windows. Cary : SAS Institute.
-
(1999)
SAS Version 8 for Windows.
-
-
-
12
-
-
1142289538
-
Estimating cure rates from survival data: An alternative to two-component mixture models
-
Tsodikov, A. D., Ibrahim, J. G. Yakovlev, A. Y. (2003) Estimating cure rates from survival data: an alternative to two-component mixture models. J. Am. Statist. Ass., 98, 1063 1078.
-
(2003)
J. Am. Statist. Ass.
, vol.98
, pp. 1063-1078
-
-
Tsodikov, A.D.1
Ibrahim, J.G.2
Yakovlev, A.Y.3
|